Emergence of 16S rRNA methylase-producing Acinetobacter baumannii and Pseudomonas aeruginosa isolates in hospitals in Vietnam

BMC Infectious Diseases

Teruo Kirikae²  Nguyen Truong Son³  Le Thi Anh Thu³  Phan Thi Xuan³  Pham Hong Truong³  Tran Thi Thanh Nga³  Nguyen Quoc Anh⁴  Nguyen Gia Binh⁴  Truong Anh Thu⁴  Doan Mai Phuong⁴  Nguyen Viet Hung⁴  Nozomi Takeshita⁵  Norio Ohmagari⁵  Yasuyuki Kato¹  Tohru Miyoshi-Akiyama²  Tatsuya Tada² 

[1] Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku, Japan;Department of Infectious Diseases, National Center for Global Health and Medicine, Shinjuku, Tokyo 162-8655, Japan;Cho Ray Hospital, Ho Chi Minh, Vietnam;Bach Mai Hospital, Hanoi, Vietnam;Disease Control and Prevention Center, Division of Infectious Diseases, National Center for Global Health and Medicine, Shinjuku, Japan

关键词: 16S rRNA methylase;    Intensive care unit;    Aminoglycoside resistance;    Pseudomonas aeruginosa;    Acinetobacter baumannii;   

Others  :  1148066
DOI  :  10.1186/1471-2334-13-251

 received in 2012-12-19, accepted in 2013-05-07,  发布年份 2013

【 摘 要 】

Background

16S rRNA methylase-producing Gram-negative bacteria are highly resistant to all clinically important aminoglycosides. We analyzed clinical strains of 16S rRNA methylase-producing Acinetobactor baumannii and Pseudomonas aeruginosa obtained from clinical isolates in medical settings in Vietnam.

Methods

From 2008 to 2011, 101 clinical strains of A. baumannii and 15 of P. aeruginosa were isolated from patients in intensive care units (ICUs) in two medical settings in Vietnam. Antimicrobial susceptibilities were determined using the microdilution method and epidemiological analysis was performed by pulsed-field gel electrophoresis and MLST. Genes encoding the 16S rRNA methylases, OXAs and CTX-Ms were analyzed by PCR and sequence analysis.

Results

16S rRNA methylase-producing Gram-negative pathogens were detected in two hospitals in Vietnam. Of the 101 clinical isolates of A. baumannii and the 15 of P. aeruginosa isolated from two ICUs in these hospitals, 72 (71.3%) were highly resistant to amikacin, arbekacin and gentamicin, with MICs greater than 1,024 mg/L. The 16S rRNA methylases ArmA and RmtB were produced by 61 and 9 isolates of A. baumannii, respectively, and RmtB was produced by 2 isolates of P. aeruginosa. Moreover, 52 of the A. baumannii isolates producing 16S rRNA methylases harbored both blaOXA-23-like and blaOXA-51-like genes. Most A. baumannii isolates producing 16S rRNA methylase obtained in hospital A in Hanoi were ST91 and ST231, whereas most from hospital B in Ho Chi Minh City were ST136, ST195, and ST254.

The two P. aeruginosa isolates harboring rmtB showed different patterns on PFGE, one each corresponding to ST217 and ST313.

Conclusions

Gram-negative bacteria producing the 16S rRNA methylases ArmA and RmtB are emerging in medical settings in Vietnam. A. baumannii isolates in northern and southern regions of Vietnam may be of different lineages.

【 授权许可】

   
2013 Tada et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Jana S, Deb JK: Molecular understanding of aminoglycoside action and resistance. Appl Microbiol Biotechnol 2006, 70(2):140-150.
• [2]Doi Y, Arakawa Y: 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007, 45(1):88-94.
• [3]Galimand M, Courvalin P, Lambert T: Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother 2003, 47(8):2565-2571.
• [4]Yamane K, Wachino J, Suzuki S, Shibata N, Kato H, Shibayama K, Kimura K, Kai K, Ishikawa S, Ozawa Y, Konda T, Arakawa Y: 16S rRNA methylase-producing, gram-negative pathogens, Japan. Emerg Infect Dis 2007, 13(4):642-646.
• [5]Wachino J, Arakawa Y: Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update. Drug Resist Updat 2012, 15(3):133-148.
• [6]Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K, Yagi T, Kato H, Arakawa Y: Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 2003, 362(9399):1888-1893.
• [7]Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, Fujino T, Kikuchi H, Sasaki S, Watari H, Kojima T, Miki H, Kanemitsu K, Kunishima H, Kikuchi Y, Kaku M, Yoshikura H, Kuratsuji T, Kirikae T: Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 2007, 45(3):979-989.
• [8]Davis MA, Baker KN, Orfe LH, Shah DH, Besser TE, Call DR: Discovery of a gene conferring multiple-aminoglycoside resistance in Escherichia coli. Antimicrob Agents Chemother 2010, 54(6):2666-2669.
• [9]Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, Guo Y, Wang M: Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 2010, 29(11):1349-1353.
• [10]Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27(4):351-353.
• [11]Monstein HJ, Ostholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K, Nilsson LE: Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS 2007, 115(12):1400-1408.
• [12]Li DX, Zhang SM, Hu GZ, Wang Y, Liu HB, Wu CM, Shang YH, Chen YX, Du XD: Tn3-associated rmtB together with qnrS1, aac(6′)-Ib-cr and bla CTX-M-15 are co-located on an F49:A-:B- plasmid in an Escherichia coli ST10 strain in China. J Antimicrob Chemother 2012, 67(1):236-238.
• [13]Thu TA, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung NV: Antibiotic use in Vietnamese hospitals: A multicenter point-prevalence study. Am J Infect Control 2012, 40(9):840-844.
• [14]Hulscher ME, Grol RP, van der Meer JW: Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010, 10(3):167-175.
• [15]Kritsotakis EI, Dimitriadis I, Roumbelaki M, Vounou E, Kontou M, Papakyriakou P, Koliou-Mazeri M, Varthalitis I, Vrouchos G, Troulakis G, Gikas A: Case-mix adjustment approach to benchmarking prevalence rates of nosocomial infection in hospitals in Cyprus and Greece. Infect Control Hosp Epidemiol 2008, 29(8):685-692.
• [16]Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A: Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol 2005, 26(1):100-104.
• [17]Ceyhan M, Yildirim I, Ecevit C, Aydogan A, Ornek A, Salman N, Somer A, Hatipoglu N, Camcioglu Y, Alhan E, Celik U, Hacimustafaoglu M, Celebi S, Inan D, Kurt N, Oner AF, Gulumser O, Gunes A, Coskun Y: Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis 2010, 14(1):e55-e61.
• [18]Lee MK, Chiu CS, Chow VC, Lam RK, Lai RW: Prevalence of hospital infection and antibiotic use at a university medical center in Hong Kong. J Hosp Infect 2007, 65(4):341-347.
• [19]Hamouda A, Evans BA, Towner KJ, Amyes SG: Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J Clin Microbiol 2010, 48(7):2476-2483.
• [20]Libisch B, Watine J, Balogh B, Gacs M, Muzslay M, Szabo G, Fuzi M: Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res Microbiol 2008, 159(3):162-168.
• [21]Strateva T, Markova B, Marteva-Proevska Y, Ivanova D, Mitov I: Widespread dissemination of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase and ArmA 16S ribosomal RNA methylase in a Bulgarian university hospital. Braz J Infect Dis 2012, 16(3):307-310.
• [22]Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P: PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 2011, 55(5):2424-2427.
• [23]Karthikeyan K, Thirunarayan MA, Krishnan P: Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010, 65(10):2253-2254.
• [24]Kim JW, Heo ST, Jin JS, Choi CH, Lee YC, Jeong YG, Kim SJ, Lee JC: Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital. Clin Microbiol Infect 2008, 14(7):716-718.
• [25]Karah N, Haldorsen B, Hermansen NO, Tveten Y, Ragnhildstveit E, Skutlaberg DH, Tofteland S, Sundsfjord A, Samuelsen O: Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. J Med Microbiol 2011, 60(Pt 4):515-521.
• [26]Doi Y, Adams JM, Yamane K, Paterson DL: Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America. Antimicrob Agents Chemother 2007, 51(11):4209-4210.
• [27]Yamada Y, Suwabe A: Diverse carbapenem-resistant mechanisms in 16S rRNA methylase-producing Acinetobacter baumannii. J Med Microbiol 2013, 62(4):618-622.
• [28]Galimand M, Sabtcheva S, Courvalin P, Lambert T: Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob Agents Chemother 2005, 49(7):2949-2953.
• [29]Ma L, Lin CJ, Chen JH, Fung CP, Chang FY, Lai YK, Lin JC, Siu LK: Taiwan Surveillance of Antimicrobial Resistance Project: Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2009, 53(1):104-111.